State Rep. James Talarico pushes back against claims he called former Congressman Colin Allred a 'mediocre Black man,' attributing the dispute to a misinterpreted private conversation as a heated Democratic primary intensifies.
A new national survey reveals a significant majority of American voters believe the rollout of artificial intelligence is happening too rapidly, coupled with profound doubts about federal regulators' capacity to oversee the technology effectively.
A massive release of Jeffrey Epstein investigation files by the Justice Department has left survivors reeling after personal information, including names and confidential statements, was left unredacted. Lawyers allege a "historic violation" of privacy, prompting urgent calls for judicial intervention.
Insurance brokerage giant Brown & Brown is grappling with a significant talent drain to a rival, launching legal action to stem the flow, while also mourning the loss of its top lawyer. These challenges unfold against a backdrop of a sharply declining share price, raising questions about the firm's near-term stability and strategic direction.
Adtalem Global Education posts strong Q2 fiscal 2026 results, raising revenue to $503.39M and net income to $76.38M, while reaffirming full-year guidance. The company's new $750M share repurchase authorization signals a dual commitment to capital returns and strategic growth in its healthcare education portfolio, even as regulatory and enrollment challenges linger.
Pfizer has secured global rights to Novavax's Matrix-M adjuvant technology, aiming to develop new vaccines for infectious diseases as it seeks to diversify its portfolio beyond pandemic-related sales.
Peloton Interactive announces a major restructuring, cutting jobs primarily in tech and corporate roles as new CEO Peter Stern prioritizes cash flow and operational efficiency over expansion, amid a prolonged stock slump and intense competition.
Despite a recent stock pullback, ServiceNow's accelerating AI monetization, expanding CRM footprint, and robust operational execution are building a compelling case for long-term growth, analysts say.
Snap Inc. is showing signs of a financial turnaround, powered by its surging Snapchat+ subscription service and strategic AI investments. As daily active users approach half a billion, analysts are reassessing the social media pioneer's long-term potential.
Laura Fernández of the Sovereign People's Party secures the presidency, vowing to extend outgoing leader Rodrigo Chaves's tough-on-crime policies as the nation grapples with escalating violence.
Karman Holdings, a recent NYSE entrant, is capturing Wall Street's attention with its pivotal role in next-generation missile and hypersonic systems. As U.S. defense budgets swell, can this premium-valued contractor justify its lofty multiples?
Once a high-flying SaaS leader, PagerDuty now trades near historic lows despite its critical role in digital operations. As the company navigates a painful pricing model transition, improving fundamentals and persistent takeover speculation present a compelling bull case for patient investors.
A growing backlash in Italy targets the planned participation of U.S. Immigration and Customs Enforcement officers in the upcoming Winter Games, with critics labeling their presence incompatible with Italian values.
Facing negative pricing at the Waha hub, APA Corporation slashed significant U.S. natural gas and liquids production in late 2025. Simultaneously, the company aggressively repurchased shares, highlighting a capital allocation strategy that prioritizes shareholder returns over volume growth in a volatile market.
Gökçe Güven, CEO of rewards startup Kalder and a 2023 Forbes 30 Under 30 honoree, is charged with securities fraud, wire fraud, and visa fraud. Prosecutors allege she used falsified data to raise millions from investors.
While Winter Storm Devin triggered JetBlue's late-December collapse, a closer look reveals a fragile operational system, concentrated network, and strained labor relations that pose significant ongoing risks for the airline and its investors.
Gilead Sciences, the biopharma giant known for its HIV treatments, is strategically pivoting to become a major player in cancer therapy. Through targeted licensing and a focus on precision oncology, the company aims to build a multi-billion dollar revenue stream by the end of the decade, reducing its reliance on mature franchises.
Facing the looming patent expiration of key drugs Revlimid and Eliquis, Bristol-Myers Squibb is making a strategic pivot, acquiring Orbital Therapeutics for $1.5 billion to pioneer in vivo RNA therapies. This high-stakes move aims to redefine the company's growth in oncology and autoimmune diseases.
The aerospace and engine leasing specialist defied a mid-year slump with a powerful earnings beat, propelling its stock to a stellar annual gain. Now, with the launch of its FTAI Power data center initiative, the company is aiming to capitalize on the AI-driven energy crunch.
Exclusive BBC analysis reveals nearly half of accredited zoos and aquariums in the UK and Ireland have sounded financial alarms since 2022, forcing tough choices between conservation missions and economic reality.
